Compare FRD & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FRD | AIRS |
|---|---|---|
| Founded | 1965 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Medical/Nursing Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.3M | 114.6M |
| IPO Year | 1995 | 2021 |
| Metric | FRD | AIRS |
|---|---|---|
| Price | $17.63 | $2.69 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 22.7K | ★ 3.5M |
| Earning Date | 05-18-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.93% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.46 | N/A |
| Revenue | $121,157,278.00 | ★ $180,350,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.55 |
| P/E Ratio | $12.05 | ★ N/A |
| Revenue Growth | ★ 55.82 | N/A |
| 52 Week Low | $12.24 | $1.51 |
| 52 Week High | $24.37 | $12.00 |
| Indicator | FRD | AIRS |
|---|---|---|
| Relative Strength Index (RSI) | 42.37 | 60.02 |
| Support Level | $15.58 | $1.73 |
| Resistance Level | $20.60 | $3.29 |
| Average True Range (ATR) | 0.81 | 0.31 |
| MACD | -0.08 | 0.12 |
| Stochastic Oscillator | 40.40 | 64.57 |
Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.